Mecwell Pharma Machinery Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.79 Cr
- Revenue Growth 12.13%
- Profit Growth 42.81%
- Ebitda 115.14%
- Net Worth 81.52%
- Total Assets 4.29%
About Mecwell Pharma Machinery
Mecwell Pharma Machinery Private Limited (MPMPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 June 2016 (Eight years and seven months 25 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.79 Cr.
Govindbhai Panchal and Harshad Panchal serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U29297MH2016PTC282822
-
Company No.
282822
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jun 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Mecwell Pharma Machinery?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govindbhai Panchal
|
Director | 23-Jun-2016 | Current |
|
Harshad Panchal
|
Director | 23-Jun-2016 | Current |
Financial Performance of Mecwell Pharma Machinery.
Mecwell Pharma Machinery Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.13% increase. The company also saw a substantial improvement in profitability, with a 42.81% increase in profit. The company's net worth Soared by an impressive increase of 81.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mecwell Pharma Machinery?
In 2023, Mecwell Pharma Machinery had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹17.87 M
₹0
Charges Breakdown by Lending Institutions
- Tjsb Sahakari Bank Limited : 1.79 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Feb 2023 | Tjsb Sahakari Bank Limited | ₹1.79 Cr | Open |
How Many Employees Work at Mecwell Pharma Machinery?
Unlock and access historical data on people associated with Mecwell Pharma Machinery, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mecwell Pharma Machinery, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mecwell Pharma Machinery's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.